What does CUSIP 686164AC8 represent in this 13F holders report?

CUSIP 686164AC8 is the security identifier for 686164AC8 - OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 used to aggregate holder disclosures.

How many institutions held 686164AC8 - OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 in Q2 2018?

No institutional holders were reported for 686164AC8 - OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 in Q2 2018; review adjacent reporting periods for trend context.

OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0

CUSIP: 686164AC8

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Debt / NOTE 2.750%12/0
Total 13F principal: $0
Principal change: -$3,378,000
Total reported market value: $0
Number of holders: 0
Value change: -$236,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 686164AC8?
CUSIP 686164AC8 identifies 686164AC8 - OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2018

Recent filing periods for CUSIP 686164AC8:

Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017

OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0

Q2 2018 13F Holders as of 30 Jun 2018

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 as of Q2 2018.